Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-11 2:00 pm Unchanged | 2025-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Rosalind Advisors Inc. | 464,676 9.900% | 0 (Unchanged) | Filing History |
| 2026-02-11 1:58 pm Purchase | 2025-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC | Rosalind Advisors Inc. | 2,746,840 9.800% | 670,000 (+32.26%) | Filing History |
| 2026-02-11 12:59 pm Unchanged | 2025-12-31 | 13G | MediWound Ltd. MDWD | Rosalind Advisors Inc. | 912,319 7.000% | 0 (Unchanged) | Filing History |
| 2026-02-11 12:10 pm Sale | 2025-12-31 | 13G | PolyPid Ltd. PYPD | Rosalind Advisors Inc. | 5,483,443 9.900% | -222,112 (-3.89%) | Filing History |
| 2026-02-11 11:50 am Unchanged | 2025-12-31 | 13G | InspireMD, Inc. NSPR | Rosalind Advisors Inc. | 10,987,104 9.200% | 0 (Unchanged) | Filing History |
| 2026-02-11 11:31 am Sale | 2025-12-31 | 13G | Biofrontera Inc. BFRI | Rosalind Advisors Inc. | 16,188,781 9.900% | -588,236 (-3.51%) | Filing History |
| 2026-02-11 10:58 am Sale | 2025-12-31 | 13G | Talphera, Inc. TLPH | Rosalind Advisors Inc. | 13,150,954 9.900% | -806,484 (-5.78%) | Filing History |
| 2026-02-11 10:50 am Purchase | 2025-12-31 | 13G | Myomo, Inc. MYO | Rosalind Advisors Inc. | 7,603,030 9.900% | 48,984 (+0.65%) | Filing History |
| 2026-02-10 3:23 pm Sale | 2025-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors Inc. | 247,715 5.500% | -1,377 (-0.55%) | Filing History |
| 2026-02-10 2:41 pm Purchase | 2025-12-31 | 13D | Delcath Systems, Inc. DCTH | Rosalind Advisors Inc. | 6,719,993 9.900% | 45,000 (+0.67%) | Filing History |
| 2025-11-13 4:08 pm Purchase | 2025-09-30 | 13G | Fennec Pharmaceuticals Inc. FENC | Rosalind Advisors Inc. | 2,076,840 7.500% | 2,076,840 (New Position) | Filing History |
| 2025-11-13 11:40 am Purchase | 2025-09-30 | 13G | Talphera, Inc. TLPH | Rosalind Advisors Inc. | 13,957,438 9.900% | 6,314,923 (+82.63%) | Filing History |
| 2025-11-12 2:52 pm Purchase | 2025-10-27 | 13G | Biofrontera Inc. BFRI | Rosalind Advisors Inc. | 16,777,017 9.900% | 2,344,945 (+16.25%) | Filing History |
| 2025-11-12 1:31 pm Sale | 2025-09-30 | 13G | PolyPid Ltd. PYPD | Rosalind Advisors Inc. | 5,705,555 9.900% | -56,794 (-0.99%) | Filing History |
| 2025-11-12 11:42 am Purchase | 2025-09-30 | 13G | MediWound Ltd. MDWD | Rosalind Advisors Inc. | 912,319 7.000% | 341,993 (+59.96%) | Filing History |
| 2025-11-12 11:03 am Purchase | 2025-09-30 | 13G | Myomo, Inc. MYO | Rosalind Advisors Inc. | 7,554,046 9.900% | 195,000 (+2.65%) | Filing History |
| 2025-08-13 2:43 pm Purchase | 2025-06-30 | 13G | PolyPid Ltd. PYPD | Rosalind Advisors Inc. | 5,762,349 9.900% | 1,681,261 (+41.20%) | Filing History |
| 2025-08-13 1:56 pm Sale | 2025-06-30 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Rosalind Advisors Inc. | 464,676 9.900% | -250,555 (-35.03%) | Filing History |
| 2025-08-12 11:40 am Sale | 2025-06-30 | 13G | MediWound Ltd. MDWD | Rosalind Advisors Inc. | 570,326 5.200% | -99,832 (-14.90%) | Filing History |
| 2025-08-11 5:04 pm Sale | 2025-06-30 | 13G | OptiNose, Inc. OPTN | Rosalind Advisors Inc. | 0 0.000% | -343,781 (Position Closed) | Filing History |